DocMorris AG (DocMorris AG) Momentum Rank : 0 (As of Jun. 24, 2024)

View and export this data going back to 2018. Start your Free Trial

What is DocMorris AG Momentum Rank?

DocMorris AG has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

DocMorris AG Momentum Rank Related Terms

Thank you for viewing the detailed overview of DocMorris AG's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

DocMorris AG (DocMorris AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (OTCPK:ZRSEF) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

DOCMz:UK 0RRB:UK DOCM:Switzerland

Address

Walzmuhlestrasse 60, Frauenfeld, CHE, 8500

Website

https://www.zurrosegroup.com

DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.